Stay updated on Checkpoint Inhibition+Immunoboost in Solid Tumors (CHEERS) Clinical Trial
Sign up to get notified when there's something new on the Checkpoint Inhibition+Immunoboost in Solid Tumors (CHEERS) Clinical Trial page.

Latest updates to the Checkpoint Inhibition+Immunoboost in Solid Tumors (CHEERS) Clinical Trial page
- Check3 days agoChange DetectedThe completed CHEERS phase II trial record is available, describing its comparison of checkpoint inhibitor treatment alone versus treatment combined with radiotherapy, along with study outcomes, eligibility criteria, locations, and publications.SummaryDifference57%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check24 days agoChange DetectedA banner announces NIH website transition updates and says some content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedUsers attempting to view the study page are now presented with a 403 Forbidden error instead of the study details. This indicates an access restriction or site issue that prevents the page from loading.SummaryDifference19%

Stay in the know with updates to Checkpoint Inhibition+Immunoboost in Solid Tumors (CHEERS) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Checkpoint Inhibition+Immunoboost in Solid Tumors (CHEERS) Clinical Trial page.